Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Stinson

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
BMC Genomics|July 9, 2017
Massively parallel nanowell-based single-cell gene expression profilingLeonard D Goldstein, Ying-Jiun Jasmine Chen, Jude Dunne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2012
Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patientsSara A Hurvitz, David J Betting, Howard M Stern, et al.
Cancer Discovery|May 16, 2012
PPM1H is a p27 phosphatase implicated in trastuzumab resistanceSi Tuen Lee-Hoeflich, Thinh Q Pham, Don Dowbenko, et al.
Genome Research|January 24, 2012
The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patientsZhaoshi Jiang, Suchit Jhunjhunwala, Jinfeng Liu, et al.
Nature|May 28, 2010
The mutation spectrum revealed by paired genome sequences from a lung cancer patientWilliam Lee, Zhaoshi Jiang, Jinfeng Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2012
Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancersChaitali Parikh, Vasantharajan Janakiraman, Wen-I Wu, et al.
BMC Medical Genetics|February 15, 2018
Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South IndiaViswanathan Mohan, Venkatesan Radha, Thong T Nguyen, et al.
Cancer Cell|December 8, 2009
Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activationBijay S Jaiswal, Vasantharajan Janakiraman, Noelyn M Kljavin, et al.
Science Translational Medicine|March 18, 2011
CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphomaBart Burington, Peng Yue, Xiaoyan Shi, et al.
Nature|August 17, 2012
Recurrent R-spondin fusions in colon cancerSomasekar Seshagiri, Eric W Stawiski, Steffen Durinck, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
BMC Genomics|July 9, 2017
Massively parallel nanowell-based single-cell gene expression profilingLeonard D Goldstein, Ying-Jiun Jasmine Chen, Jude Dunne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2012
Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patientsSara A Hurvitz, David J Betting, Howard M Stern, et al.
Cancer Discovery|May 16, 2012
PPM1H is a p27 phosphatase implicated in trastuzumab resistanceSi Tuen Lee-Hoeflich, Thinh Q Pham, Don Dowbenko, et al.
Genome Research|January 24, 2012
The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patientsZhaoshi Jiang, Suchit Jhunjhunwala, Jinfeng Liu, et al.
Nature|May 28, 2010
The mutation spectrum revealed by paired genome sequences from a lung cancer patientWilliam Lee, Zhaoshi Jiang, Jinfeng Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2012
Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancersChaitali Parikh, Vasantharajan Janakiraman, Wen-I Wu, et al.
BMC Medical Genetics|February 15, 2018
Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South IndiaViswanathan Mohan, Venkatesan Radha, Thong T Nguyen, et al.
Cancer Cell|December 8, 2009
Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activationBijay S Jaiswal, Vasantharajan Janakiraman, Noelyn M Kljavin, et al.
Science Translational Medicine|March 18, 2011
CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphomaBart Burington, Peng Yue, Xiaoyan Shi, et al.
Nature|August 17, 2012
Recurrent R-spondin fusions in colon cancerSomasekar Seshagiri, Eric W Stawiski, Steffen Durinck, et al.
Pageof 4